Thermo Fisher Scientific Inc (NYSE: TMO), a company involved in serving science, announced on Tuesday that it has named Paul G Parker as its new senior vice president, strategy and corporate development effective 15 April 2020.
Parker will report to Marc N Casper, chairman, president and chief executive officer, and will be based in Waltham, Massachusetts.
Parker joins from Goldman Sachs & Co, where he served for six years as co-chairman of Global Mergers & Acquisitions and as a member of the firm's Partnership Committee. His investment banking career covers 35 years, having held various global operating and senior client relationship roles at Goldman Sachs and other financial services firms including Barclays, Lehman Brothers and JP Morgan. Parker is a graduate of Harvard Business School and The University of North Carolina at Chapel Hill.
Nuevocor names new chief medical officer
ELIAS Animal Health names new chief revenue officer
enGene Holdings names new senior vice president, Urologic Oncology and Clinical Development
HealthTrackRx names new chief medical officer
PureTech announces launch of Seaport Therapeutics with USD100m Series A financing
REVIAN names new vice president of Healthcare Sales
Orsini Specialty Pharmacy names new CFO and EVP of Trade Relations and Account Management
Ligand Pharmaceuticals launches Pelthos Therapeutics to drive ZELSUVMI commercialisation
Soligenix announces agreement on design for second Phase 3 trial for HyBryte with EMA
Ratio Therapeutics names new chief business officer and director
Trevi Therapeutics names new vice president of Clinical Development
NeoImmuneTech names new president and chief executive officer